Opus Genetics, Inc. (IRD)
CIK 1228627 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 83.2M shares as of Aug 3, 2026 (10-Q). Share count fell from 48.3M to 4.0M between Mar 7, 2019 and May 10, 2019, a pattern consistent with a reverse split (roughly 1-for-12); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Warrant Exercise Price One | 18.4M | $0.95 | 3.7y | — |
| Pre Funded Warrants | 16.0M | $0.0001 | — | — |
| March2025 Warrants | 8.8M | $1.425 | 5y | FV $58.6M |
| November2025 Registered Direct Offering | 7.2M | not tagged | — | — |
| Warrant Exercise Price Two | 1.2M | $1.15 | 3.7y | — |
| March2025 Private Placement Warrants | 392,157 | $1.725 | 5y | FV $3.5M |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 19.6M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $9.6 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $62.1M as of Jun 30, 2026.
Rough fully diluted estimate: 102.8M = 83.2M O/S + 19.6M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 6, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Registrations and offerings
Registered offering capacity on live registrations: $347.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 5 executed · 4 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full IRD workspace